Form D · Biotechnology
Hilltop Biosciences Inc.
Norwood, MA · CIK 0001782084
Offering snapshot reported Mar 31, 2025 · SEC filing
- Reported sold
- $5.3M Offering amount: $5.5M
- Investors reported
- 73 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 27, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,300,000 → $5,303,565
- Reported investors6 → 73
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2025 | Amendment | $5,303,565 | $1,003,565vs Dec 12, 2024 | 73 | SEC filing |
| Dec 12, 2024 | Initial | $4,300,000 | No comparison | 6 | SEC filing |
| Apr 3, 2023 | Amendment | $723,524 | $353,605vs Feb 17, 2023 | 42 | SEC filing |
| Feb 17, 2023 | Amendment | $369,919 | $74,999vs Jan 3, 2023 | 35 | SEC filing |
| Jan 3, 2023 | Initial | $294,920 | No comparison | 31 | SEC filing |
| Oct 4, 2021 | Amendment | $866,345 | $82,025vs Aug 27, 2021 | 67 | SEC filing |
| Aug 27, 2021 | Initial | $784,320 | No comparison | Not reported | SEC filing |
| May 29, 2020 | Initial | $149,746 | No comparison | 21 | SEC filing |
| Jul 11, 2019 | Initial | $750,854 | No comparison | 48 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531956
Source: Form D, filed Mar 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Denise Beavers | Director |
| Denise Bevers | Director |
| Amanda Drobnis | Director, Executive |
| Jessica Mc Lear | Director |
| Alan Watson | Director |
| Mark Williams | Director, Executive |
| Jill Wittels | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
320 Norwood Park, S
Norwood, MA, 02062
Norwood, MA, 02062